Click on headlines below to download research

Enrolment for China study adjusted
ASLAN Pharmaceuticals | 19/09/2018

ASLAN announced it would be amending the protocol for its ongoing Chinese pivotal trial of varlitinib in biliary tract cancer (BTC). The patients being…

ASLAN004 a go for atopic dermatitis
ASLAN Pharmaceuticals | 09/07/2018

ASLAN announced in July 2018 that it has received clinical trial authorisation in Singapore to conduct a Phase I study of ASLAN004 for the treatment of…

Additional clinical support for varlitinib
ASLAN Pharmaceuticals | 07/06/2018

ASLAN presented data at ASCO from a Phase Ib dosing study examining varlitinib in combination with carboplatin, paclitaxel and Herceptin. Patients were…